chr1-196779219-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021023.6(CFHR3):c.116G>T(p.Arg39Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000196 in 1,529,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R39C) has been classified as Uncertain significance.
Frequency
Consequence
NM_021023.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.116G>T | p.Arg39Leu | missense_variant | 2/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.116G>T | p.Arg39Leu | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.116G>T | p.Arg39Leu | missense_variant | 2/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.116G>T | p.Arg39Leu | missense_variant | 2/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.116G>T | p.Arg39Leu | missense_variant | 2/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.116G>T | p.Arg39Leu | missense_variant, NMD_transcript_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000731 AC: 1AN: 136846Hom.: 0 Cov.: 25
GnomAD3 exomes AF: 0.00000420 AC: 1AN: 238338Hom.: 0 AF XY: 0.00000778 AC XY: 1AN XY: 128476
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1392544Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 691562
GnomAD4 genome AF: 0.00000731 AC: 1AN: 136846Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 66484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.116G>T (p.R39L) alteration is located in exon 2 (coding exon 2) of the CFHR3 gene. This alteration results from a G to T substitution at nucleotide position 116, causing the arginine (R) at amino acid position 39 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at